The European Medicines Agency and the European Parliament have both called for an early decision on the new location of the EMA as the agency prepares for the upheaval that will be caused by the UK’s decision to leave the EU.
A quick decision on the agency’s future location would “help us to transition and to recruit new staff to be...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?